{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:42:49Z","timestamp":1792078969007,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jaut.2015.07.008","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T13:03:18Z","timestamp":1437915798000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":533,"special_numbering":"C","title":["The immunogenetics of Psoriasis: A comprehensive review"],"prefix":"10.1016","volume":"64","author":[{"given":"Jamie L.","family":"Harden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2015.07.008_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. pathology"},{"key":"10.1016\/j.jaut.2015.07.008_bib3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib5","doi-asserted-by":"crossref","first-page":"805705","DOI":"10.1155\/2013\/805705","article-title":"Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches","volume":"2013","author":"Colombo","year":"2013","journal-title":"The Scientific World J."},{"key":"10.1016\/j.jaut.2015.07.008_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.07.008_bib10","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2015.07.008_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/jid.2008.225","article-title":"Resident and \u201cinflammatory\u201d dendritic cells in human skin","volume":"129","author":"Zaba","year":"2009","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib12","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12505638","article-title":"Psoriasis vulgaris: a genetic approach","volume":"95","author":"Wuepper","year":"1990","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.genom.6.080604.162324","article-title":"The genetics of psoriasis and autoimmunity","volume":"6","author":"Bowcock","year":"2005","journal-title":"Annu. Rev. genomics Hum. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.jid.5700357","article-title":"PSORS1: linking genetics and immunology","volume":"126","author":"Elder","year":"2006","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib15","doi-asserted-by":"crossref","first-page":"e97282","DOI":"10.1371\/journal.pone.0097282","article-title":"HLA diversity in the 1000 genomes dataset","volume":"9","author":"Gourraud","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2015.07.008_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A\u00a0genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ng.690","article-title":"Association analyses identify six new psoriasis susceptibility loci in the Chinese population","volume":"42","author":"Sun","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib18","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1038\/ncomms7916","article-title":"Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility","volume":"6","author":"Yin","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2015.07.008_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2014.07.002","article-title":"Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes","volume":"95","author":"Okada","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.it.2008.04.007","article-title":"NKG2D ligands: key targets of the immune response","volume":"29","author":"Gonzalez","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","article-title":"Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u201cType 1\u201d inflammatory gene expression","volume":"25","author":"Lew","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaci.2014.05.046","article-title":"Humanized anti-IFN-gamma (HuZAF) in the treatment of psoriasis","volume":"135","author":"Harden","year":"2015","journal-title":"J.\u00a0allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in\u00a0vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.07.008_bib26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.jid.5701255","article-title":"Polymorphisms of the IL12B and IL23R genes are associated with psoriasis","volume":"128","author":"Nair","year":"2008","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A\u00a0large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib29","doi-asserted-by":"crossref","first-page":"e17160","DOI":"10.1371\/journal.pone.0017160","article-title":"The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans","volume":"6","author":"Di Meglio","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2015.07.008_bib30","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1074\/jbc.272.9.6073","article-title":"Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases","volume":"272","author":"Zou","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2015.07.008_bib31","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A\u00a0receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajhg.2012.02.020","article-title":"Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci","volume":"90","author":"Ellinghaus","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib33","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","article-title":"Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis","volume":"133","author":"Sofen","year":"2014","journal-title":"J.\u00a0allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature14175","article-title":"Clinical improvement in psoriasis with specific targeting of interleukin-23","volume":"521","author":"Kopp","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.07.008_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.13932","article-title":"Tildrakizumab (MK-3222), an Anti- IL-23p19 Monoclonal Antibody, Improves Psoriasis in a Phase 2b Randomized Placebo- Controlled Trial","author":"Papp","year":"2015","journal-title":"Br. J. Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543784.2013.806483","article-title":"IL-17 targeted therapies for psoriasis","volume":"22","author":"Chiricozzi","year":"2013","journal-title":"Expert Opin. Investigational Drugs"},{"key":"10.1016\/j.jaut.2015.07.008_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ni1424","article-title":"Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells","volume":"8","author":"Djuretic","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2567.2010.03381.x","article-title":"Interplay of transcription factors in T-cell differentiation and function: the role of Runx","volume":"132","author":"Wong","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2015.07.008_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fgene.2013.00254","article-title":"Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem\/progenitor cells","volume":"4","author":"Faridi","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature05673","article-title":"Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1","volume":"446","author":"Ono","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.07.008_bib42","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1084\/jem.20090226","article-title":"Runx proteins regulate Foxp3 expression","volume":"206","author":"Bruno","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2009.09.003","article-title":"Indispensable role of the Runx1-Cbfbeta transcription complex for in\u00a0vivo-suppressive function of FoxP3+ regulatory T cells","volume":"31","author":"Kitoh","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.07.008_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1268","article-title":"A\u00a0putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis","volume":"35","author":"Helms","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/exd.12128","article-title":"Studies of Jak\/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity","volume":"22","author":"Andres","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2015.07.008_bib46","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: An in\u00a0vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jdermsci.2013.06.007","article-title":"Epidermal hyperplasia induced by Raf-MAPK signaling requires Stat3 activation","volume":"72","author":"Tarutani","year":"2013","journal-title":"J.\u00a0Dermatological Sci."},{"key":"10.1016\/j.jaut.2015.07.008_bib48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ygeno.2003.12.019","article-title":"T\u00a0lymphocyte activation gene identification by coregulated expression on DNA microarrays","volume":"83","author":"Mao","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.jaut.2015.07.008_bib49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng.102","article-title":"Newly identified genetic risk variants for celiac disease related to the immune response","volume":"40","author":"Hunt","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib50","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ng.479","article-title":"Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk","volume":"41","author":"Raychaudhuri","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib51","doi-asserted-by":"crossref","first-page":"e1001283","DOI":"10.1371\/journal.pgen.1001283","article-title":"A\u00a0meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease","volume":"7","author":"Festen","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib52","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ana.22609","article-title":"Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci","volume":"70","author":"Patsopoulos","year":"2011","journal-title":"Ann. Neurology"},{"key":"10.1016\/j.jaut.2015.07.008_bib53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.gene.6364451","article-title":"Variants in the 5q31 cytokine gene cluster are associated with psoriasis","volume":"9","author":"Chang","year":"2008","journal-title":"Genes Immun."},{"key":"10.1016\/j.jaut.2015.07.008_bib54","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood-2012-09-378653","article-title":"Essentials of Th17 cell commitment and plasticity","volume":"121","author":"Muranski","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2015.07.008_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2567.2011.03483.x","article-title":"Helper T-cell differentiation and plasticity: insights from epigenetics","volume":"134","author":"Hirahara","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2015.07.008_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jaci.2012.04.041","article-title":"Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases","volume":"130","author":"Li","year":"2012","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-kappaB: an essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J.\u00a0Dermatological Sci."},{"key":"10.1016\/j.jaut.2015.07.008_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-kappaB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jaut.2015.07.008_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-kappaB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2015.07.008_bib60","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-kappaB\/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib61","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","article-title":"Genome-wide association analysis identifies three psoriasis susceptibility loci","volume":"42","author":"Stuart","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib62","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/jid.2013.315","article-title":"c-Rel downregulation affects cell cycle progression of human keratinocytes","volume":"134","author":"Lorenz","year":"2014","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib63","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.688","article-title":"Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis","volume":"42","author":"Huffmeier","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib65","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.autrev.2014.01.050","article-title":"The IL-23\/IL-17 axis in psoriatic arthritis","volume":"13","author":"Suzuki","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2015.07.008_bib66","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.cellsig.2010.11.022","article-title":"Signaling of interleukin-17 family cytokines in immunity and inflammation","volume":"23","author":"Chang","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jaut.2015.07.008_bib67","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/jid.2014.383","article-title":"Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6","volume":"135","author":"Wu","year":"2015","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/cr.2010.182","article-title":"NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins","volume":"21","author":"Blonska","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.jaut.2015.07.008_bib69","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib70","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib71","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/jcp.22667","article-title":"Alternative splicing of CARMA2\/CARD14 transcripts generates protein variants with differential effect on NF-kappaB activation and endoplasmic reticulum stress-induced cell death","volume":"226","author":"Scudiero","year":"2011","journal-title":"J.\u00a0Cell. physiology"},{"key":"10.1016\/j.jaut.2015.07.008_bib72","doi-asserted-by":"crossref","first-page":"e111255","DOI":"10.1371\/journal.pone.0111255","article-title":"CARD14 expression in dermal endothelial cells in Psoriasis","volume":"9","author":"Harden","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2015.07.008_bib73","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3389\/fimmu.2013.00468","article-title":"Sensing microbial RNA in the cytosol","volume":"4","author":"Vabret","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib74","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fimmu.2014.00342","article-title":"Pattern recognition and signaling mechanisms of RIG-I and MDA5","volume":"5","author":"Reikine","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jir.1994.14.229","article-title":"The type I interferon system is locally activated in psoriatic lesions","volume":"14","author":"Schmid","year":"1994","journal-title":"J.\u00a0Interferon Res."},{"key":"10.1016\/j.jaut.2015.07.008_bib76","doi-asserted-by":"crossref","first-page":"e2737","DOI":"10.1371\/journal.pone.0002737","article-title":"Type I interferon: potential therapeutic target for psoriasis?","volume":"3","author":"Yao","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2015.07.008_bib77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered","volume":"122","author":"van der Fits","year":"2004","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib78","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jdermsci.2006.11.003","article-title":"Cytokine modulation of retinoic acid-inducible gene-I (RIG-I) expression in human epidermal keratinocytes","volume":"45","author":"Kitamura","year":"2007","journal-title":"J.\u00a0Dermatological Sci."},{"key":"10.1016\/j.jaut.2015.07.008_bib79","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2133.2010.10169.x","article-title":"Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes","volume":"164","author":"Racz","year":"2011","journal-title":"Br. J. Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib80","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/sj.jid.5701087","article-title":"IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis","volume":"128","author":"Prens","year":"2008","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib81","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/hmg\/ddr215","article-title":"Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis","volume":"20","author":"Bijlmakers","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib82","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/jid.2010.214","article-title":"Carriers of rare missense variants in IFIH1 are protected from psoriasis","volume":"130","author":"Li","year":"2010","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib83","doi-asserted-by":"crossref","first-page":"e0115354","DOI":"10.1371\/journal.pone.0115354","article-title":"SRSF1 facilitates cytosolic DNA-induced production of type I interferons recognized by RIG-I","volume":"10","author":"Xue","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2015.07.008_bib84","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib85","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1038\/ncomms7793","article-title":"Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis","volume":"6","author":"Zuo","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2015.07.008_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cytogfr.2012.04.002","article-title":"Emerging roles for TNIP1 in regulating post-receptor signaling","volume":"23","author":"Ramirez","year":"2012","journal-title":"Cytokine & Growth Factor Rev."},{"key":"10.1016\/j.jaut.2015.07.008_bib87","doi-asserted-by":"crossref","first-page":"18482","DOI":"10.1074\/jbc.M601502200","article-title":"ABIN-1 binds to NEMO\/IKKgamma and co-operates with A20 in inhibiting NF-kappaB","volume":"281","author":"Mauro","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2015.07.008_bib88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng.310","article-title":"Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib89","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib90","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus","volume":"41","author":"Han","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib91","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ng.200","article-title":"Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus","volume":"40","author":"Graham","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib92","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1083\/jcb.145.7.1471","article-title":"The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN","volume":"145","author":"Heyninck","year":"1999","journal-title":"J.\u00a0cell Biol."},{"key":"10.1016\/j.jaut.2015.07.008_bib93","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.abb.2011.08.014","article-title":"TNIP1 is a corepressor of agonist-bound PPARs","volume":"516","author":"Flores","year":"2011","journal-title":"Archives Biochem. biophysics"},{"key":"10.1016\/j.jaut.2015.07.008_bib94","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/jid.2011.348","article-title":"A\u00a0subset of methylated CpG sites differentiate psoriatic from normal skin","volume":"132","author":"Roberson","year":"2012","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib95","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2015.07.008_bib96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/BJ20130019","article-title":"Zc3h12c inhibits vascular inflammation by repressing NF-kappaB activation and pro-inflammatory gene expression in endothelial cells","volume":"451","author":"Liu","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.jaut.2015.07.008_bib97","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1074\/jbc.M707861200","article-title":"A\u00a0novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages","volume":"283","author":"Liang","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2015.07.008_bib98","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib99","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2015.07.008_bib100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2012.00020","article-title":"SOCS, Inflammation, and Autoimmunity","volume":"3","author":"Yoshimura","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2015.07.008_bib101","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-065X.2003.00020.x","article-title":"Regulation of cytokine receptor signaling by SOCS1","volume":"192","author":"Ilangumaran","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2015.07.008_bib102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2302\/kjm.58.73","article-title":"Regulation of cytokine signaling by the SOCS and Spred family proteins","volume":"58","author":"Yoshimura","year":"2009","journal-title":"Keio J. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008946","article-title":"Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema","volume":"6","author":"Quaranta","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib104","first-page":"76","article-title":"A\u00a0specific molecular signature for psoriasis and eczema","volume":"3","author":"Coimbra","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002400000148","article-title":"Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer","volume":"29","author":"Uotila","year":"2001","journal-title":"Urological Res."},{"key":"10.1016\/j.jaut.2015.07.008_bib106","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.0.CO;2-O","article-title":"Selective expression of inducible nitric oxide synthase in human prostate carcinoma","volume":"82","author":"Klotz","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jaut.2015.07.008_bib107","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1172\/JCI42059","article-title":"Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients","volume":"120","author":"Glynn","year":"2010","journal-title":"J.\u00a0Clin. Investigation"},{"key":"10.1016\/j.jaut.2015.07.008_bib108","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1073\/pnas.1401799111","article-title":"Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression","volume":"111","author":"Heinecke","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2015.07.008_bib109","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20121277","article-title":"Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling","volume":"210","author":"Obermajer","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family. Journal of interferon & cytokine research","volume":"30","author":"Donnelly","year":"2010","journal-title":"Official J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.jaut.2015.07.008_bib111","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.21312","article-title":"Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes","volume":"44","author":"Doyle","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib112","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in\u00a0vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2015.07.008_bib113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/exd.12604","article-title":"Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis","volume":"24","author":"Lovendorf","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2015.07.008_bib114","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/exd.12469","article-title":"Genetic polymorphisms altering microRNA activity in psoriasis\u2013a key to solve the puzzle of missing heritability?","volume":"23","author":"Pivarcsi","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2015.07.008_bib115","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jcmm.12359","article-title":"A\u00a0single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study","volume":"18","author":"Zhang","year":"2014","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.jaut.2015.07.008_bib116","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1523-1747.ep12285389","article-title":"Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis","volume":"86","author":"Nanney","year":"1986","journal-title":"J.\u00a0Investigative Dermatology"},{"key":"10.1016\/j.jaut.2015.07.008_bib117","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2015.07.008_bib118","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/tpj.2012.53","article-title":"Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases","volume":"13","author":"Prieto-Perez","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jaut.2015.07.008_bib119","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/jid.2011.376","article-title":"TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis","volume":"132","author":"Tejasvi","year":"2012","journal-title":"J.\u00a0Investigative Dermatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:13:04Z","timestamp":1760256784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841115300111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":119,"alternative-id":["S0896841115300111"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2015.07.008","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunogenetics of Psoriasis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2015.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}